Compare APG & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APG | PODD |
|---|---|---|
| Founded | 1926 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 17.0B |
| IPO Year | 2019 | 2007 |
| Metric | APG | PODD |
|---|---|---|
| Price | $45.59 | $171.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 21 |
| Target Price | $46.33 | ★ $341.48 |
| AVG Volume (30 Days) | ★ 2.7M | 902.9K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.86 | N/A |
| EPS | N/A | ★ 3.48 |
| Revenue | N/A | ★ $2,708,100,000.00 |
| Revenue This Year | $8.86 | $24.55 |
| Revenue Next Year | $6.04 | $19.18 |
| P/E Ratio | ★ N/A | $46.25 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $32.70 | $158.35 |
| 52 Week High | $51.95 | $354.88 |
| Indicator | APG | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 26.93 |
| Support Level | $34.04 | N/A |
| Resistance Level | $46.50 | $205.95 |
| Average True Range (ATR) | 1.43 | 7.04 |
| MACD | 0.03 | -1.91 |
| Stochastic Oscillator | 31.31 | 26.32 |
APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.